4.7 Review

The application of antidepressant drugs in cancer treatment

Related references

Note: Only part of the references are listed.
Article Cell Biology

The Death Receptor Pathway of Apoptosis

Douglas R. Green

Cold Spring Harbor Perspectives in Biology (2022)

Article Pharmacology & Pharmacy

Antidepressants Fluoxetine Mediates Endoplasmic Reticulum Stress and Autophagy of Non-Small Cell Lung Cancer Cells Through the ATF4-AKT-mTOR Signaling Pathway

Shali Shao et al.

Summary: This study discovered that fluoxetine inhibits the growth of lung cancer cells by activating the ER stress pathway and inhibiting the AKT/mTOR pathway, leading to cell cycle arrest and autophagy. Importantly, fluoxetine does not affect the proliferation of normal cells, providing a safe therapeutic strategy for lung cancer patients.

FRONTIERS IN PHARMACOLOGY (2022)

Article Oncology

The antidepressant imipramine inhibits breast cancer growth by targeting estrogen receptor signaling and DNA repair events

Santosh Timilsina et al.

Summary: The anti-depressant imipramine can block the growth of breast cancer by inducing cell cycle arrest and inhibiting DNA repair activities. Imipramine inhibits the expression of cell cycle and DNA repair associated proteins and also inhibits estrogen receptor signaling. It can enhance the sensitivity of triple-negative breast cancer to PARP inhibitors and endocrine resistant breast cancer to anti-estrogens.

CANCER LETTERS (2022)

Review Biochemistry & Molecular Biology

Antiproliferative Effects of St. John's Wort, Its Derivatives, and Other Hypericum Species in Hematologic Malignancies

Alessandro Allegra et al.

Summary: Hypericum, widely used as a therapeutic cure for depression, skin wounds, and respiratory and inflammatory disorders, also demonstrates various biological actions such as anti-infective, anti-oxidant, and spasmolytic abilities. Recent studies have shown its potential in the treatment of pathological conditions like trigeminal neuralgia and cancer. In hematologic malignancies, Hypericum induces apoptosis in myeloid and lymphoid cells, and targets mediators of cell migration and angiogenesis. Furthermore, it downregulates proteins involved in leukemia cell resistance to chemotherapeutic agents, making it a potential candidate for tumor photodynamic therapy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Biochemistry & Molecular Biology

Anti-Tumor Activity of Hypericum perforatum L. and Hyperforin through Modulation of Inflammatory Signaling, ROS Generation and Proton Dynamics

Marta Menegazzi et al.

Summary: St. John's wort and its active component hyperforin exhibit antitumor effects by reducing ROS production, restoring pH imbalance in tumor cells, inhibiting mitochondrial ROS generation, and preventing proliferation, neo-angiogenesis, and metastatic dissemination.

ANTIOXIDANTS (2021)

Article Oncology

The selective serotonin reuptake inhibitors enhance the cytotoxicity of sorafenib in hepatocellular carcinoma cells

Huan Zhang et al.

Summary: Sertraline and fluoxetine can inhibit the growth of hepatocellular carcinoma (HCC) cells by blocking the AKT/mTOR pathway and synergize with sorafenib in inhibiting HCC cell viability, revealing novel therapeutic effects in HCC treatment.

ANTI-CANCER DRUGS (2021)

Article Environmental Sciences

The proliferation effects of fluoxetine and amitriptyline on human breast cancer cells and the underlying molecular mechanisms

Bingli Lei et al.

Summary: The study revealed that fluoxetine activates the PI3K/AKT and ERK signaling cascades via GPR30 to induce breast cancer cell proliferation, which can be attenuated by inhibitors.

ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2021)

Article Oncology

Suppression of EGFR/PKC-δ/NF-κB Signaling Associated With Imipramine-Inhibited Progression of Non-Small Cell Lung Cancer

Po-Fu Yueh et al.

Summary: The study found that imipramine effectively induces apoptosis of NSCLC cells by suppressing the EGFR/PKC-d/NF-κB pathway, leading to increased DNA damage and decreased invasion and migration potential. In both in vitro and in vivo models, imipramine demonstrated tumor growth inhibition similar to the standard therapy erlotinib (EGFR inhibitor). Non-obvious body weight loss and liver pathology changes were observed in mice treated with imipramine.

FRONTIERS IN ONCOLOGY (2021)

Article Chemistry, Medicinal

Discovery of sertraline and its derivatives able to combat drug-resistant gastric cancer cell via inducing apoptosis

Chao Mu et al.

Summary: The study found that the antidepressant drug sertraline could sensitize drug-resistant gastric cancer cells, and through the synthesis and evaluation of 30 derivatives, the activity of the best compound was significantly improved. Additionally, it was discovered that apoptosis induction and cell cycle arrest were the reasons for the death of drug-resistant cells, involving the PI3K/Akt/mTOR pathway.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2021)

Article Biochemistry & Molecular Biology

Synergistic Growth Inhibition of HT-29 Colon and MCF-7 Breast Cancer Cells with Simultaneous and Sequential Combinations of Antineoplastics and CNS Drugs

Diana Duarte et al.

Summary: The study found that fluphenazine, fluoxetine, and benztropine showed enhanced anticancer activity when used alone in colorectal cancer; sertraline was identified as a promising candidate for drug repurposing in breast cancer; sertraline and thioridazine in combination with 5-FU exhibited the strongest synergism in colorectal cancer cells.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Cell Biology

Imipramine impedes glioma progression by inhibiting YAP as a Hippo pathway independent manner and synergizes with temozolomide

Yan Wang et al.

Summary: The study demonstrates that imipramine inhibits the proliferation of malignant glioma by suppressing YAP, and concurrent use with temozolomide shows synergistic effects in inhibiting tumor growth.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Article Oncology

Sensitizing TRAIL-resistant A549 lung cancer cells and enhancing TRAIL-induced apoptosis with the antidepressant amitriptyline

K. M. A. Zinnah et al.

Summary: The study demonstrated the mechanism behind the synergistic anticancer effect of amitriptyline and TRAIL, showing that amitriptyline increases TRAIL-induced apoptosis by upregulating death receptors DR4 and DR5. Inhibition of autophagy by amitriptyline was also shown to enhance DR4 and DR5 expression.

ONCOLOGY REPORTS (2021)

Article Oncology

Repositioning of duloxetine to target pancreatic stellate cells

Akiko Sagara et al.

Summary: The study identified compounds that can suppress PSC activation by targeting the 'neuroactive ligand-receptor interaction' pathway, leading to disruption of tumor-stromal interaction. Among these compounds, duloxetine was found to have this suppressive effect.

ONCOLOGY LETTERS (2021)

Article Biochemistry & Molecular Biology

Pimozide and Imipramine Blue Exploit Mitochondrial Vulnerabilities and Reactive Oxygen Species to Cooperatively Target High Risk Acute Myeloid Leukemia

Zhengqi Wang et al.

Summary: Recent studies have shown that combining pimozide with mTOR inhibitors and BH3 mimetics is effective in AML cells. In Flt3-ITD+ cells, pimozide combined with IB can act through the Drp1-p38-ROS pathway. Overall, rational combination therapies show promise for improving responses in AML patients.

ANTIOXIDANTS (2021)

Article Biochemistry & Molecular Biology

Fluoxetine Simultaneously Induces Both Apoptosis and Autophagy in Human Gastric Adenocarcinoma Cells

Wah Wah Po et al.

BIOMOLECULES & THERAPEUTICS (2020)

Article Pharmacology & Pharmacy

Apoptotic effect of fluoxetine through the endoplasmic reticulum stress pathway in the human gastric cancer cell line AGS

Phyu Phyu Khin et al.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2020)

Article Biochemistry & Molecular Biology

New role of the antidepressant imipramine as a Fascin1 inhibitor in colorectal cancer cells

Begona Alburquerque-Gonzalez et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2020)

Article Medicine, Research & Experimental

Inhibition of autophagy flux by sertraline attenuates TRAIL resistance in lung cancer via death receptor 5 upregulation

Kazi Mohammad Ali Zinnah et al.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2020)

Review Biochemistry & Molecular Biology

Lactic Acid and an Acidic Tumor Microenvironment suppress Anticancer Immunity

Joy X. Wang et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Biochemistry & Molecular Biology

Is there any potential anticancer effect of raloxifene and fluoxetine on DMBA-induced rat breast cancer?

Oguzhan Tatar et al.

JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2019)

Article Cell Biology

Anticancer activity of paroxetine in human colon cancer cells: Involvement of MET and ERBB3

Won-Jun Jang et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)

Review Medicine, General & Internal

Inflammation and Cancer

Nitin Singh et al.

ANNALS OF AFRICAN MEDICINE (2019)

Review Oncology

The broken cycle: E2F dysfunction in cancer

Lindsey N. Kent et al.

NATURE REVIEWS CANCER (2019)

Review Pharmacology & Pharmacy

The Use of Antidepressants for Physical and Psychological Symptoms in Cancer

Syahrir Zaini et al.

CURRENT DRUG TARGETS (2018)

Article Medicine, Research & Experimental

Repurposing sertraline sensitizes non-small cell lung cancer cells to erlotinib by inducing autophagy

Xingwu Jiang et al.

JCI INSIGHT (2018)

Article Pharmacology & Pharmacy

Amitriptyline down-regulates coenzyme Q10 biosynthesis in lung cancer cells

Tamara Ortiz et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2017)

Article Multidisciplinary Sciences

Imipramine blue sensitively and selectively targets FLT3-ITD positive acute myeloid leukemia cells

Jonathan Metts et al.

SCIENTIFIC REPORTS (2017)

Article Medicine, Research & Experimental

Baicalein increases cisplatin sensitivity of A549 lung adenocarcinoma cells via PI3K/Akt/NF-κB pathway

Meiling Yu et al.

BIOMEDICINE & PHARMACOTHERAPY (2017)

Review Medicine, Research & Experimental

A current perspective on the oncopreventive and oncolytic properties of selective serotonin reuptake inhibitors

Daniel P. Radin et al.

BIOMEDICINE & PHARMACOTHERAPY (2017)

Review Oncology

Global Cancer Incidence and Mortality Rates and Trends-An Update

Lindsey A. Torre et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2016)

Article Oncology

Fluoxetine regulates cell growth inhibition of interferon-α

Yu-Min Lin et al.

INTERNATIONAL JOURNAL OF ONCOLOGY (2016)

Article Cell Biology

Histone Modifications and Cancer

James E. Audia et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)

Article Cell Biology

Oncostatic effects of fluoxetine in experimental colon cancer models

Vinicius Kannen et al.

CELLULAR SIGNALLING (2015)

Review Oncology

Antidepressant fluoxetine and its potential against colon tumors

Helga Stopper et al.

WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2014)

Article Pharmacology & Pharmacy

The Role of Paroxetine in Fatigue and Depression of Patients Under Chemotherapeutic Treatment

Panagiotis Heras et al.

AMERICAN JOURNAL OF THERAPEUTICS (2013)

Review Anesthesiology

Neuropathic pain in cancer

M. T. Fallon

BRITISH JOURNAL OF ANAESTHESIA (2013)

Article Biochemistry & Molecular Biology

Amitriptyline may have a supportive role in cancer treatment by inhibiting glutathione S-transferase pi (GST-π) and alpha (GST-α)

Gulnihal Kulaksiz-Erkmen et al.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2013)

Review Biochemistry & Molecular Biology

MYC on the Path to Cancer

Chi V. Dang

Article Biochemistry & Molecular Biology

DNA-Binding Studies of Fluoxetine Antidepressant

Soheila Kashanian et al.

DNA AND CELL BIOLOGY (2012)

Article Multidisciplinary Sciences

Mirtazapine Inhibits Tumor Growth via Immune Response and Serotonergic System

Chun-Kai Fang et al.

PLOS ONE (2012)

Article Biochemistry & Molecular Biology

The tricyclic antidepressant imipramine induces autophagic cell death in U-87MG glioma cells

Seung-Hyun Jeon et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)

Review Pharmacology & Pharmacy

Drug Interaction in Psycho-Oncology: Antidepressants and Antineoplastics

C. Miguel et al.

PHARMACOLOGY (2011)

Article Pharmacology & Pharmacy

Fluoxetine mediates G0/G1 arrest by inducing functional inhibition of cyclin dependent kinase subunit (CKS)1

Anand Krishnan et al.

BIOCHEMICAL PHARMACOLOGY (2008)

Review Biochemistry & Molecular Biology

The role of mitochondria in apoptosis

Seon-Yong Jeong et al.

BMB REPORTS (2008)

Review Pharmacology & Pharmacy

Tricyclic antidepressant pharmacology and therapeutic drug interactions updated

P. K. Gillman

BRITISH JOURNAL OF PHARMACOLOGY (2007)

Review Clinical Neurology

Review of the epidemiological literature on antidepressant use and breast cancer risk

Patricia F. Coogan

EXPERT REVIEW OF NEUROTHERAPEUTICS (2006)

Article Physiology

Mechanism of block of hEag1 K+ channels by imipramine and astemizole

RE García-Ferreiro et al.

JOURNAL OF GENERAL PHYSIOLOGY (2004)

Review Biochemistry & Molecular Biology

Mechanisms of caspase activation and inhibition during apoptosis

YG Shi

MOLECULAR CELL (2002)

Article Gastroenterology & Hepatology

Akt protects mouse hepatocytes from TNF-α- and Fas-mediated apoptosis through NK-κB activation

E Hatano et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2001)